Related references
Note: Only part of the references are listed.Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon
Marc G. Ghany
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA
Man Zhang et al.
CELL RESEARCH (2016)
Clinical Efficacy of Therapy with Recombinant Human Interferon a1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection
Xueyong Huang et al.
PLOS ONE (2016)
Effects of HDV infection and pegylated interferon a treatment on the natural killer cell compartment in chronically infected individuals
Sebastian Lunemann et al.
GUT (2015)
Activation of endogenous type I IFN signaling contributes to persistent HCV infection
Yujia Li et al.
REVIEWS IN MEDICAL VIROLOGY (2014)
CD81 and Hepatitis C Virus (HCV) Infection
Lucie Feneant et al.
VIRUSES-BASEL (2014)
The DeISGylase USP18 limits TRAIL-induced apoptosis through the regulation of TRAIL levels Cellular levels of TRAIL influences responsiveness to TRAIL-induced apoptosis
Ivana Manini et al.
CANCER BIOLOGY & THERAPY (2013)
Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10
Christoph Burkart et al.
EMBO MOLECULAR MEDICINE (2013)
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus
Nadine Honke et al.
NATURE IMMUNOLOGY (2012)
The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in Hepatitis C Virus infection and resistance to interferon therapy
Limin Chen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Usp18 Regulates Epidermal Growth Factor (EGF) Receptor Expression and Cancer Cell Survival via MicroRNA-7
Jason E. Duex et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response
Veronique Francois-Newton et al.
PLOS ONE (2011)
Identification of USP18 as an Important Regulator of the Susceptibility to IFN-α and Drug-Induced Apoptosis
Harish Potu et al.
CANCER RESEARCH (2010)
Emerging Role of ISG15 in Antiviral Immunity
Brian Skaug et al.
CELL (2010)
Cell-Type Specific Gene Expression Signature in Liver Underlies Response to Interferon Therapy in Chronic Hepatitis C Infection
Limin Chen et al.
GASTROENTEROLOGY (2010)
The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response
Ruth Broering et al.
GUT (2010)
ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment
Limin Chen et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Hepatitis C Virus Controls Interferon Production through PKR Activation
Noella Arnaud et al.
PLOS ONE (2010)
RNA Interference Screen Identifies Usp18 as a Regulator of Epidermal Growth Factor Receptor Synthesis
Jason E. Duex et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
The Level of Hepatitis B Virus Replication Is Not Affected by Protein ISG15 Modification but Is Reduced by Inhibition of UBP43 (USP18) Expression
Jung-Hwan Kim et al.
JOURNAL OF IMMUNOLOGY (2008)
Negative feedback regulation of RIG-1-mediated antiviral signaling by interferon-induced ISG15 conjugation
Min-Jung Kim et al.
JOURNAL OF VIROLOGY (2008)
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C
T. Asselah et al.
GUT (2008)
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
Jordan J. Feld et al.
HEPATOLOGY (2007)
Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection
Glenn Randall et al.
GASTROENTEROLOGY (2006)
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity
Oxana A. Malakhova et al.
EMBO JOURNAL (2006)
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
CL Jopling et al.
SCIENCE (2005)
Complete replication of hepatitis C virus in cell culture
BD Lindenbach et al.
SCIENCE (2005)
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection
LM Chen et al.
GASTROENTEROLOGY (2005)
Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection
KJ Ritchie et al.
NATURE MEDICINE (2004)
The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase
S Tokarz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells
JA Wilson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
UBP43 (USP18) specifically removes ISG15 from conjugated proteins
MP Malakhov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient
T Kato et al.
JOURNAL OF MEDICAL VIROLOGY (2001)
Share Paper
